Top 10 Healthcare Market Research Companies in the World (2025)
IQVIA is widely regarded as the gold standard in healthcare data analytics and real-world evidence generation. With operations in over 100 countries and access to more than 1.2 billion de-identified patient records, IQVIA delivers an unparalleled combination of technology, clinical research, and commercial insight.
Their offerings include advanced AI-powered analytics, health economics & outcomes research (HEOR), and contract research organization (CRO) services. IQVIA’s healthcare-grade AI platform helps pharma companies accelerate development, optimize launches, and understand patient populations more precisely.
Kantar Health, now operating as Cerner Enviza following its acquisition by Cerner, brings deep therapeutic domain expertise combined with rigorous market research methodology.
With more than 600 healthcare specialists worldwide, they offer evidence-based research that spans epidemiology, brand tracking, patient and physician segmentation, and payer research. Their clinical and commercial intelligence supports pharmaceutical, biotech, and diagnostics companies through the entire lifecycle.
Clarivate is a global analytics company offering transformative intelligence, especially in life sciences.
They provide solutions that combine epidemiology data, incidence/prevalence databases, and claims-based population insights to help biopharma precisely assess patient populations and forecast market size. Their patient data intelligence platforms provide anonymized prescribing and treatment patterns, enabling strategic decisions around market access, launch, and competitive positioning.
DelveInsight is a specialized, research-driven life sciences intelligence firm. They are known for their rich pipelines of disease-area reports, epidemiology studies, and competitive landscape analyses. Their deep-dive market research helps pharma and biotech companies evaluate therapeutic opportunities, forecast market demand, and plan strategic development. DelveInsight’s strength lies in combining disease biology, regulatory trends, and commercial metrics to deliver actionable insights.
Syneos Health is a full-service bio-pharma solutions organization with a strong presence in real-world evidence and market research. Their Insight & Strategy division advises companies on launch planning, HEOR frameworks, and commercial strategies, while their RWE unit leverages large datasets to validate hypotheses about patient journeys, treatment patterns, and outcomes. Their integrated model bridges clinical development and market insight, making them a preferred partner for complex pharma launches.
ICON is a global clinical research organization (CRO) with extensive healthcare intelligence capabilities.
Beyond its CRO services, ICON provides market research, strategic advisory, and data analytics to pharmaceutical and biotech clients. Their insights help align clinical development with commercial potential, informing decisions from early-stage trial design to post-market strategy.
Merative (formerly IBM Watson Health) specializes in advanced analytics, real-world data, and artificial intelligence for healthcare.
With strong capabilities in medical research, Merative supports life sciences firms in generating real-world evidence, building predictive models, and optimizing outcomes. Their cloud-based analytics platforms are designed to accelerate evidence generation and improve decision-making for drug development and commercialization.
GlobalHealth Intelligence is a leading provider of market intelligence focused on healthcare infrastructure, device markets, and emerging geographies. Their proprietary datasets and on-ground expertise help clients assess market potential, competitive dynamics, and growth opportunities, particularly in fast-growing regions.
Boutique intelligence firms like Clarion Healthcare offer tailored strategic research to life sciences clients. These firms typically specialize in disease modeling, competitive intelligence, and go-to-market advisory. Their nimble structure enables bespoke projects with actionable deliverables and close collaboration.
Although traditionally known as a CRO or consultancy, companies like Parexel have robust market research and advisory arms that support pharmaceutical clients with market access insights, HEOR, and regulatory intelligence. These hybrid firms leverage clinical trial expertise and technical advisory to deliver tailored market intelligence.
Artificial intelligence is transforming market research in healthcare. Leading firms are embedding generative AI, predictive modeling, and machine learning into their platforms, enabling faster data processing and more nuanced insights.
Strong demand for RWE is reshaping traditional research. Market intelligence now routinely combines real-world health data from EHRs, claims databases, and patient-reported outcomes to produce insights that reflect real-world performance.
Disease incidence/prevalence modeling, enabled by epidemiology intelligence platforms, is becoming essential to assess commercial opportunity, forecast patient populations, and prioritize therapeutic campaigns.
Healthcare research is no longer dominated by North America and Western Europe. Firms with data on emerging markets are increasingly valuable, as pharma and medtech companies look to expand in LATAM, Asia, and Africa.
The boundary between clinical development, commercial strategy, and health-economics advisory is blurring. Leading market research firms now offer end-to-end capabilities from pipeline assessment to launch planning to post-market surveillance.
Executives: Strategic decisions around R&D investment, therapeutic prioritization, and market entry increasingly rely on data-driven forecasting.
Pharma / Biotech: Understanding patient populations, payer behavior, and competitor pipelines is critical for product development and commercialization.
Investors: High-quality market research reduces risk by validating market size, identifying unmet needs, and assessing competitive intensity before deploying capital.
As the healthcare industry continues to pivot toward value-based care, real-world data, and technology-driven innovation, market research firms are evolving to meet new demands. The top 10 healthcare market research companies in 2025 combine domain expertise, data infrastructure, and strategic advisory to provide actionable insights that matter. Whether you are a pharma executive planning your next launch, an investor evaluating a biotech opportunity, or a health system leader seeking competitive intelligence, partnering with one or more of these firms can yield a competitive edge in a complex and dynamic ecosystem.